Development and marketing of pharmaceuticals in respiratory, neonatology, transplantation, and rare diseases.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
LES LABORATOIRES SERVIER INDUSTRIE
A
Development and marketing of pharmaceuticals in the fields of oncology, cardiometabolism, and neurology.
Orphan Europe
B
Development and commercialization of drugs for rare diseases.
Takeda
B
Development and commercialization of innovative medicines in various therapeutic areas, including gastrointestinal diseases, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Initiatives identified among leaders
Contribuer à améliorer le taux de survie des enfants atteints de cancer
“LES LABORATOIRES SERVIER INDUSTRIE contribue à amé...” - LES LABORATOIRES SERVIER INDUSTRIERéduction des déchets et des émissions de CO2
“Takeda réduit ses déchets et ses émissions de CO2” - Takedaoctroi de subventions pour la recherche scientifique
“Orphan Europe octroie des subventions pour la rech...” - Orphan Europe61% of similar organizations communicate on CSR issues
+4500 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports